For how long should treatment with clopidogrel be continued after coronary stent implantation?

被引：1

作者：

Rozenman, Y ^{[1
]}

机构：

[1] E Wolfson Med Ctr, IL-58100 Holon, Israel

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2004年 / 43卷 / 07期

关键词：

D O I：

10.1016/j.jacc.2004.01.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1331 / 1331

页数：1

共 4 条

[1] Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival - Results from the do tirofiban and ReoPro give similar efficacy outcome trial (TARGET) [J].

Chan, AW ;

Moliterno, DJ ;

Berger, PB ;

Stone, GW ;

DiBattiste, PM ;

Yakubov, SL ;

Sapp, SK ;

Wolski, K ;

Bhatt, DL ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1188-1195

[2] Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J].

Mehta, SR ;

Yusuf, S ;

Peters, RJG ;

Bertrand, ME ;

Lewis, BS ;

Natarajan, MK ;

Maimberg, K ;

Rupprecht, HJ ;

Zhao, F ;

Chrolavicius, S ;

Copland, I ;

Fox, KAA .

LANCET, 2001, 358 (9281) :527-533

[3] Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial [J].

Steinhubl, SR ;

Berger, PB ;

Mann, JT ;

Fry, ETA ;

DeLago, A ;

Wilmer, C ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2411-2420

[4] Platelet inhibition strategies in percutaneous coronary intervention - Competition or cooperation? [J].

Tcheng, JE ;

Campbell, ME .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1196-1198

← 1 →